GRHL2 expression functions in breast cancer aggressiveness and could serve as prognostic and diagnostic biomarker for breast cancer (vol 16, pg 1, 2022)

被引：0
|
作者：
Bai, Xiaoyu
Li, Yue
Li, Yanlei
Li, Fan
Che, Na
Ni, Chusheng
Zhao, Nan
Zhao, Xiulan
Liu, Tieju
机构：
来源：
CLINICAL MEDICINE INSIGHTS-ONCOLOGY | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The prognostic significance of ERβ1, -2 and -5 expression in breast cancer.
    Shaaban, A. M.
    Green, A. R.
    Karthik, S.
    Alizadeh, Y.
    Ellis, I. O.
    Robertson, J. F. R.
    Paish, C.
    Saunders, P. T. K.
    Groome, N. P.
    Harkins, L.
    Speirs, V
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S10 - S10
  • [22] Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines
    Yang, Liying
    Kumegawa, Kohei
    Saeki, Sumito
    Nakadai, Tomoyoshi
    Maruyama, Reo
    CANCER GENE THERAPY, 2024, 31 (05) : 736 - 745
  • [23] Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines
    Liying Yang
    Kohei Kumegawa
    Sumito Saeki
    Tomoyoshi Nakadai
    Reo Maruyama
    Cancer Gene Therapy, 2024, 31 : 736 - 745
  • [24] VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer (vol 20, pg 91, 2019)
    Holding, Andrew N.
    Giorgi, Federico M.
    Donnelly, Amanda
    Cullen, Amy E.
    Nagarajan, Sankari
    Selth, Luke A.
    Markowetz, Florian
    GENOME BIOLOGY, 2019, 20 (1)
  • [25] Study of serum microRNA-99a relative expression as a diagnostic and prognostic noninvasive biomarker of breast cancer in Egyptian females
    Yousif, Anas A.
    Eisa, Hesham A.
    Nawar, Ahmed M.
    El-latif, Mai S. Abd
    Behiry, Eman G.
    GENE REPORTS, 2020, 19
  • [26] HnRNPA2/B1Is a Novel Prognostic Biomarker for Breast Cancer Patients
    Ma, Yuehong
    Yang, Lizhu
    Li, Rongshan
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2020, 24 (11) : 701 - 707
  • [27] Computational assessment of MCM2 transcriptional expression and identification of the prognostic biomarker for human breast cancer
    Samad, Abdus
    Haque, Farhana
    Nain, Zulkar
    Alam, Rahat
    Al Noman, Abdullah
    Molla, Mohammad Habibur Rahman
    Hossen, Saddam
    Islam, Raquibul
    Khan, Iqbal
    Ahammad, Foysal
    HELIYON, 2020, 6 (10)
  • [28] Circulating HER-2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer
    Wu, Yanlin
    Meng, Qiping
    Yang, Zhixue
    Shi, Lili
    Hu, Rongkuan
    Zhang, Peizhuo
    Wei, Jinrong
    Ren, Jie
    Leng, Bingjing
    Xu, Dong
    Jiang, Guo-Qin
    ONCOLOGY LETTERS, 2018, 16 (03) : 3726 - 3734
  • [29] Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer
    Rui, Tao
    Xiang, Aizhai
    Guo, Jufeng
    Tang, Ning
    Lin, Xia
    Jin, Xin
    Liu, Jian
    Zhang, Xiaobing
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [30] Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer (vol 33, pg 769, 2022)
    Van Baelen, K.
    Geukens, T.
    Maetens, M.
    Tjan-Heijnen, V.
    Lord, C. J.
    Linn, S.
    Bidard, F. -C.
    Richard, F.
    Yang, W. W.
    Steele, R. E.
    Pettitt, S. J.
    Van Ongeval, C.
    De Schepper, M.
    Isnaldi, E.
    Nevelsteen, I.
    Smeets, A.
    Punie, K.
    Voorwerk, L.
    Wildiers, H.
    Floris, G.
    Salomon, A. Vincent
    Derksen, P. W. B.
    Neven, P.
    Senkus, E.
    Sawyer, E.
    Kok, M.
    Desmedt, C.
    ANNALS OF ONCOLOGY, 2023, 34 (03) : 326 - 326
12345